Cost-effectiveness evaluation of mirabegron versus anti-muscarinics and third-line therapies: a systematic review
Year: 2022
Type: review
Study design: Systematic Review
Language: English
Subfield: Urology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4297965543
